Greatmark Investment Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,645
Closed -$2.58M 122
2022
Q2
$2.58M Sell
12,645
-4,869
-28% -$993K 0.5% 46
2022
Q1
$3.69M Buy
17,514
+3,735
+27% +$786K 0.61% 36
2021
Q4
$3.31M Buy
13,779
+4,448
+48% +$1.07M 0.56% 38
2021
Q3
$2.64M Buy
9,331
+206
+2% +$58.3K 0.49% 41
2021
Q2
$3.16M Buy
9,125
+2,780
+44% +$963K 0.57% 39
2021
Q1
$1.78M Buy
6,345
+1,870
+42% +$523K 0.35% 53
2020
Q4
$1.1M Sell
4,475
-322
-7% -$78.9K 0.24% 58
2020
Q3
$1.36M Buy
4,797
+847
+21% +$240K 0.34% 51
2020
Q2
$1.06M Sell
3,950
-1,220
-24% -$326K 0.28% 57
2020
Q1
$1.64M Sell
5,170
-5
-0.1% -$1.58K 0.53% 44
2019
Q4
$1.54M Buy
5,175
+680
+15% +$202K 0.38% 51
2019
Q3
$1.05M Buy
4,495
+410
+10% +$95.5K 0.29% 57
2019
Q2
$955K Buy
4,085
+295
+8% +$69K 0.29% 59
2019
Q1
$896K Buy
3,790
+35
+0.9% +$8.27K 0.28% 56
2018
Q4
$1.13M Buy
3,755
+235
+7% +$70.7K 0.4% 49
2018
Q3
$1.24M Buy
3,520
+45
+1% +$15.9K 0.39% 53
2018
Q2
$1.01M Buy
3,475
+155
+5% +$45K 0.35% 53
2018
Q1
$909K Sell
3,320
-15
-0.4% -$4.11K 0.33% 56
2017
Q4
$1.06M Buy
3,335
+950
+40% +$303K 0.38% 54
2017
Q3
$747K Buy
2,385
+1,180
+98% +$370K 0.29% 61
2017
Q2
$327K Buy
1,205
+200
+20% +$54.3K 0.13% 79
2017
Q1
$275K Sell
1,005
-375
-27% -$103K 0.11% 83
2016
Q4
$391K Buy
1,380
+75
+6% +$21.3K 0.16% 71
2016
Q3
$409K Buy
1,305
+15
+1% +$4.7K 0.18% 67
2016
Q2
$312K Buy
+1,290
New +$312K 0.14% 73